GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Invion IVX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.03

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

—

FY2017FY2025

Net income

−A$8.8m

FY2017FY2025

Free cash flow

−A$3.0m

FY2017FY2025

Shareholders' equity

A$8.3m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue—A$3.7mA$4.1mA$3.3mA$2.3mA$3.5mA$3.9mA$737,713—
Gross profit−A$1.3mA$1.0mA$1.2mA$969,118A$810,505A$1.9mA$1.6mA$366,827−A$1.2m
Research and developmentA$1.3mA$2.7mA$2.9mA$2.3mA$1.5mA$1.6mA$2.2mA$363,656A$30,889
Operating income−A$8.8m−A$5.7m−A$1.6m−A$2.3m−A$1.6m−A$1.0m−A$2.5m−A$960,466−A$2.1m
Net income−A$8.8m−A$5.6m−A$1.6m−A$2.2m−A$1.5m−A$953,894−A$2.5m−A$926,507−A$2.2m
Diluted earnings per share-0.10-0.08-0.03-0.03-0.03-0.02-0.05-0.02-0.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$9.5mA$15.5mA$19.0mA$20.0mA$5.6mA$5.8mA$6.1mA$10.3mA$5.8m
Cash and short-term investmentsA$850,373A$783,526A$4.1mA$8.5mA$1.0mA$618,843A$771,313A$2.9mA$917,486
Total liabilitiesA$1.2mA$1.0mA$650,625A$462,412A$851,496A$326,822A$604,712A$2.4mA$1.8m
Debt————A$11,000A$11,000A$50,270A$20,295A$3.7m
Shareholders' equityA$8.3mA$14.4mA$18.4mA$19.6mA$4.8mA$5.4mA$5.5mA$7.9mA$4.0m
Shares outstanding86m67m64m64m58m55m55m55m24m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−A$3.0m−A$2.4m−A$1.8m−A$1.1mA$417,975−A$152,470−A$2.1mA$707,087−A$247,139
Capital spending—−A$900,000−A$2.6m−A$7.3m−A$7.3m−A$75,832−A$6,054−A$6,054−A$6,054
Free cash flow−A$3.0m−A$3.3m−A$4.4m−A$8.4m−A$6.8m−A$228,302−A$2.1mA$701,033−A$253,193
Dividends paid———————−A$982,014−A$663,450

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
RevenueA$384,707——A$1,680A$1.5mA$2.2mA$2.2mA$1.1m
Gross profit−A$477,985−A$859,565−A$731,787−A$558,498A$355,958A$647,281A$731,925A$365,963
Operating income−A$2.2m−A$3.5m−A$3.3m−A$2.0m−A$5.6m−A$1.9m−A$816,850−A$408,425
Net income−A$2.1m−A$3.6m−A$6.9m−A$1.9m−A$4.9m−A$714,173−A$784,118−A$392,059
Diluted earnings per share-0.02-0.04-0.08-0.03-0.07-0.01-0.01-0.01
Cash from operations−A$1.0m−A$1.0m−A$1.0m−A$1.0m−A$1.0m−A$1.0m−A$1.0m—
Capital spending——————−A$2.0m—
Free cash flow——————−A$3.0m—
Total assetsA$8.2mA$8.1mA$9.5mA$13.9mA$15.5mA$18.4mA$19.0mA$19.0m
Cash and short-term investmentsA$592,311A$137,543A$850,373A$736,447A$783,526A$1.9mA$4.1mA$4.1m
DebtA$1.5mA$627,680——————
Shareholders' equityA$5.3mA$5.7mA$8.3mA$13.1mA$14.4mA$17.9mA$18.4mA$16.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-54.6%-30.2%10.7%
Operating income33.7%20.2%-4.4%
Net income51.7%30.6%2.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-0.6-0.9-3.4-19.9-25.8-82.5-57.8-28.1-106.7-5.3
Price to sales8.7—5.17.817.652.515.918.4134.0—

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 20 Nov 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.